ArticleCost effectiveness and resource allocation : C/E2026
The economic burden of managing diabetes mellitus in children in Sudan: a cross-sectional study.
Article in Cost effectiveness and resource allocation : C/E, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetes mellitus is highly prevalent in Sudan and requires long-term management, placing a considerable demand on healthcare resources. This study estimates the direct and indirect costs of managing diabetes mellitus in children in Khartoum State, Sudan, and identifies factors influencing these costs.
methodsA cross-sectional study was conducted with 138 children with diabetes across three public diabetes clinics in Khartoum State. Data were collected through face-to-face interviews with caregivers via a standardized questionnaire adapted from the KNCV Tuberculosis Foundation. Direct costs included laboratory tests, medications, provider fees, food, transportation during diagnosis, follow-up visits, and hospitalizations. Indirect costs were estimated through productivity loss, whereas intangible costs were measured via the willingness-to-pay method. Regression analysis in SPSS was employed to identify factors affecting total costs.
resultsThe median annual cost of managing diabetes was 314 USD, with direct costs accounting for 74% of this total. Major cost drivers included food, lab tests, medications, and hospitalizations, with families spending 41% of their household income on diabetes care. Regression analysis indicated that male sex, combined therapy, and recent hospitalizations were associated with higher costs, whereas longer disease duration was associated with reduced costs.
conclusionDiabetes imposes a substantial financial burden on families in Khartoum, consuming a significant portion of household income and straining resources. Targeted policy interventions are essential to improve healthcare access, expand insurance coverage, and provide financial support for families managing diabetes in resource-limited settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.